KDR and non-small cell lung carcinoma: Furthermore, the humanized anti-VEGFR2 monoclonal antibody Ramucirumab was radiolabeled with copper-64 for PET imaging, demonstrating its specificity in non-small cell lung cancer (NSCLC) mouse models [118].